164 related articles for article (PubMed ID: 7489565)
1. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Manome Y; Wen PY; Hershowitz A; Tanaka T; Rollins BJ; Kufe DW; Fine HA
Cancer Immunol Immunother; 1995 Oct; 41(4):227-35. PubMed ID: 7489565
[TBL] [Abstract][Full Text] [Related]
2. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
3. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
[TBL] [Abstract][Full Text] [Related]
4. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
5. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME
Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106
[TBL] [Abstract][Full Text] [Related]
6. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
[TBL] [Abstract][Full Text] [Related]
7. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
8. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.
Liau LM; Jensen ER; Kremen TJ; Odesa SK; Sykes SN; Soung MC; Miller JF; Bronstein JM
Cancer Res; 2002 Apr; 62(8):2287-93. PubMed ID: 11956085
[TBL] [Abstract][Full Text] [Related]
9. Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.
Smilowitz HM; Joel DD; Slatkin DN; Micca PL; Nawrocky MM; Youngs K; Tu W; Coderre JA
J Neurooncol; 2000; 46(3):193-203. PubMed ID: 10902851
[TBL] [Abstract][Full Text] [Related]
10. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
[TBL] [Abstract][Full Text] [Related]
11. Experimental gliosarcoma induces chemokine receptor expression in rat brain.
Galasso JM; Stegman LD; Blaivas M; Harrison JK; Ross BD; Silverstein FS
Exp Neurol; 2000 Jan; 161(1):85-95. PubMed ID: 10683275
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor growth and metastasis of murine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secrete the JE/MCP-1 cytokine.
Huang S; Xie K; Singh RK; Gutman M; Bar-Eli M
J Interferon Cytokine Res; 1995 Jul; 15(7):655-65. PubMed ID: 7553238
[TBL] [Abstract][Full Text] [Related]
13. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
[TBL] [Abstract][Full Text] [Related]
14. Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.
Witham TF; Villa L; Yang T; Pollack IF; Okada H; Robbins PD; Chambers WH
J Neurooncol; 2003; 64(1-2):63-9. PubMed ID: 12952287
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors.
Yamashiro S; Takeya M; Nishi T; Kuratsu J; Yoshimura T; Ushio Y; Takahashi K
Am J Pathol; 1994 Oct; 145(4):856-67. PubMed ID: 7943176
[TBL] [Abstract][Full Text] [Related]
16. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12-based immunotherapy against rat 9L glioma.
Jean WC; Spellman SR; Wallenfriedman MA; Hall WA; Low WC
Neurosurgery; 1998 Apr; 42(4):850-6; discussion 856-7. PubMed ID: 9574650
[TBL] [Abstract][Full Text] [Related]
18. Incomplete tumour control following DNA vaccination against rat gliomas expressing a model antigen.
Ginzkey C; Eicker S; Marget M; Krause J; Brecht S; Westphal M; Hugo HH; Mehdorn M; Steinmann J; Hamel W
Acta Neurochir (Wien); 2013 Jan; 155(1):51-8; discussion 59. PubMed ID: 23132370
[TBL] [Abstract][Full Text] [Related]
19. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.
Tapscott SJ; Miller AD; Olson JM; Berger MS; Groudine M; Spence AM
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8185-9. PubMed ID: 8058777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]